Sino Biopharm Unit Licenses Blood Cancer Drug to Sanofi for Up to $1.53 Billion - Reuters
Sino Biopharm unit licenses blood cancer drug to Sanofi for up to $1.53 billion Reuters
Results for “Sino Biopharm”
1 story found
1 story found
Sino Biopharm unit licenses blood cancer drug to Sanofi for up to $1.53 billion Reuters